News

CAPDM Welcomes Methapharm

Monday, January 9, 2023

CAPDM welcomes new member Methapharm. Methapharm is a specialty pharmaceutical company with a focus on the acquisition, licensing, partnering, and promotion of specialty pharmaceutical products in North America. 

CAPDM Welcomes Juno Pharmaceuticals Canada

Friday, January 6, 2023

CAPDM welcomes new member Juno Pharmaceuticals Canada a specialty pharmaceutical company that focuses on branded, complex, biosimilar, and high value generics that bring meaningful savings to the Canadian Healthcare industry.   

CAPDM Welcomes Cold Chain Science Enterprises

Thursday, January 5, 2023

CAPDM welcomes new member Cold Chain Science Enterprises.  Cold Chain Science strives to make cold-chain management compliant, cost effective, and seamless.

CAPDM Submission to the PMPRB December 2022 Revised Guidelines Consultation

Monday, December 5, 2022

Submitted on behalf of the members of the Canadian Association for Pharmacy Distribution Management (CAPDM). 

Nancy Beshay appointed Senior Vice-President, Member and Regulatory Relations, CAPDM

Monday, August 15, 2022

The Canadian Association for Pharmacy Distribution Management, announces that Nancy Beshay appointed Senior Vice-President, Member and Regulatory Relations.


  

Teva Canada Appoints Michael Sine as General Manager

Monday, July 11, 2022

Teva Canada Appoints Michael Sine as NEW General Manager.
Read the Full Release 

Angelique Berg Appointed President & CEO, CAPDM

Monday, March 28, 2022

The Canadian Association for Pharmacy Distribution Management, announces that Angelique Berg has been appointed President and CEO, after having assumed the role on an interim basis since December 2021.
  

CAPDM Welcomes Paladin Labs Inc.

Thursday, January 20, 2022

CAPDM Welcomes New Member Paladin Labs Inc. With headquarters in Montréal, Canada, Paladin Labs Inc. is a leading specialty pharmaceutical company focused on acquiring or licensing emerging pharmaceuticals for the Canadian market.
 
Their dedicated sales and marketing organization has propelled Paladin to become one of Canada’s pioneers in specialty pharmaceuticals.
 

JAMP and Alvotech Announce Canadian Approval of SIMLANDI™

Thursday, January 20, 2022

January 20, 2022
JAMP and Alvotech Announce Canadian Approval of SIMLANDI™, a High-Concentration Biosimilar to Humira®, Providing Access  to Previously Unavailable Versions in Canada 

Read the Full Release

CAPDM Welcomes Aspen Canada Inc.

Thursday, January 20, 2022

CAPDM Welcomes New Member Aspen Canada Inc. Headquartered in Durban, South Africa, with offices in Oakville , Ontario , Aspen is a global specialty and branded pharmaceutical company, improving the health of patients across the world through our high quality and affordable medicines.